SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-17-069520
Filing Date
2017-11-20
Accepted
2017-11-20 06:19:09
Documents
80
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a17-20620_110q.htm 10-Q 2166565
2 EX-10.2 a17-20620_1ex10d2.htm EX-10.2 130365
3 EX-10.8 a17-20620_1ex10d8.htm EX-10.8 418824
4 EX-31.1 a17-20620_1ex31d1.htm EX-31.1 10266
5 EX-31.2 a17-20620_1ex31d2.htm EX-31.2 10114
6 EX-32.1 a17-20620_1ex32d1.htm EX-32.1 6123
7 EX-32.2 a17-20620_1ex32d2.htm EX-32.2 6122
  Complete submission text file 0001104659-17-069520.txt   12107857

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT jagx-20170930.xml EX-101.INS 2597617
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jagx-20170930.xsd EX-101.SCH 92992
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT jagx-20170930_cal.xml EX-101.CAL 85138
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jagx-20170930_def.xml EX-101.DEF 433258
12 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT jagx-20170930_lab.xml EX-101.LAB 785143
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jagx-20170930_pre.xml EX-101.PRE 627732
Mailing Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105
Business Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105 415-896-5081
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36714 | Film No.: 171212577
SIC: 2834 Pharmaceutical Preparations